Skip to main content
  • About Us
    • Overview
    • History
    • Management
    • Board of Directors
    • Our Culture
    • Contact
  • R & D
    • Telomerase
    • Imetelstat
    • Publications
  • For Patients
    • Clinical Trials
    • IMerge Study
    • IMpactMF
    • Hematologic Malignancies
    • Expanded Access Policy
Geron Logo
  • Partnering
    • Corporate Development
    • Scientific Collaborators
  • Careers
    • Opportunities
  • Investors
  • Investors
    • Press Releases
    • Events
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Analyst Coverage
    • FAQs
    • Publications
Geron Logo

Annual Reports and Proxy Statements

  • Home
  • Open About Us
    • Overview
    • History
    • Management
    • Board of Directors
    • Our Culture
    • Contact
  • Open R & D
    • Telomerase
    • Imetelstat
    • Publications
  • Open For Patients
    • Clinical Trials
    • IMerge Study
    • IMbark Study
    • Hematologic Malignancies
    • Expanded Access Policy
  • Open Partnering
    • Corporate Development
    • Scientific Collaborators
  • Open Careers
    • Opportunities
  • Open Investors
  • Terms of Use
  • Privacy Policy
« SEC Filings
  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • About Us
    • Overview
    • History
    • Management
    • Board of Directors
    • Our Culture
    • Contact
  • R & D
    • Telomerase
    • Imetelstat
    • Publications
  • For Patients
    • Clinical Trials
    • IMerge Study
    • IMpactMF Study
    • Hematologic Malignancies
    • Expanded Access Policy
  • Partnering
    • Corporate Development
    • Scientific Collaborators
  • Careers
    • Opportunities
  • Investors
    • Press Releases
    • Events
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Analyst Coverage
    • FAQs
    • Publications
Back To Top
Copyright © GeronAll rights reserved
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
Powered By Q4 Inc. 5.56.0.1 (opens in new window)